# US 2017/0362556 A1 · Systems and Methods for Aseptic Sampling

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0362556 A1
- Document ID: US20170362556A1
- Status: Published application
- Kind: A1
- Application number: 15/532,594
- Filed: 2015-12-04
- Published: 2017-12-21
- Earliest claimed: 2014-12-09
- Assignees: GE Healthcare Bio-Sciences AB
- Applicants: Ge Healthcare Bio-Sciences Corp.
- Inventors: Yasser Ali
- Web page: https://patentgrep.com/patent/US20170362556A1

## CPC

- C12M 23/40: {Manifolds; Distribution pieces (fluid transfer means B01L3/563)}
- C12M 33/06: {for multiple inoculation or multiple collection of samples}
- C12M 37/00: {Means for sterilizing, maintaining sterile conditions or avoiding chemical or biological contamination (C12M23/38 takes precedence; filtration in general and filters per se B01D24/00-B01D41/00; autoclaves B01J3/04; treatment of microorganisms with electrical or wave energy C12N13/00)}
- B01L 3/563: {Joints or fittings; Separable fluid transfer means to transfer fluids between at least two containers, e.g. connectors}
- C12M 41/00: {Means for regulation, monitoring, measurement or control, e.g. flow regulation (controlling or regulating chemical, physical or physicochemical processes B01J19/0006; heating or cooling apparatus for laboratory use B01L7/00; electro optical investigation of individual particles, flow cytometers G01N15/14; automatic analysis G01N35/00; controlling or regulating in general G06N)}
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE

## Abstract

A product and method for sampling cells from a bioreactor, for the purposes of determine the cell count or to remove a sample and retain sterility of the sample for quality control (OC) assessment. More specifically, a product and a method for sampling of cells during a cell expansion in a bioreactor using vacuum tubes.

## Claims

### Claim 1

A sampling device comprising:
a first conduit comprising a first port and a second port, wherein said first port is configured to be fluidly connected to a bioreactor and wherein said second port is fluidly connected to a venting device;
a plurality of sub-conduits having corresponding sub-ports, wherein each of the plurality of sub-conduits is fluidly connected to the first conduit at respective connector junctions, and wherein each of the sub-ports is fluidly connected to the first conduit and configured to be operatively coupled to a vacuum tube;
a plurality of flow controllers disposed along said first conduit between each of said connector junctions and disposed along each of said sub-conduits between said connector junction and said sub-port;
a plurality of vacuum tubes each configured to be operatively coupled to a respective sub-port of a corresponding sub-conduit.

### Claim 2 (depends on 1)

The sampling device as defined in claim 1 wherein said venting device is a syringe.

### Claim 3 (depends on 1)

The sampling device as defined in claim 1 wherein each of said plurality of flow controllers is a clamp.

### Claim 4 (depends on 1)

The sampling device as defined in claim 1 wherein each sub-port comprises a needle-provided access device and wherein a fluid path is created through the needle of the access device.

### Claim 5 (depends on 1)

The sampling device as defined in claim 1 wherein the vacuum tube is empty.

### Claim 6 (depends on 1)

The sampling device as defined in claim 1 wherein vacuum tube contains a cell viability stain.

### Claim 7 (depends on 6)

The sampling device as defined in claim 6 wherein the cell viability stain is taken from DRAQ5, Hoechst, or propidium iodide.

### Claim 8 (depends on 1)

The sampling device as defined in claim 1 wherein vacuum tube contains single antibodies.

### Claim 9 (depends on 1)

The sampling device as defined in claim 1 wherein vacuum tube contains multiple antibodies.

### Claim 10 (depends on 8)

The sampling device as defined in claim 8 wherein vacuum tube contains anti-CD3, anti-CD4 or anti-CD8.

### Claim 11 (depends on 1)

The sampling device as defined in claim 1 further comprising an air filter operatively coupled to the venting device.

### Claim 12 (depends on 1)

The sampling device as defined in claim 1 wherein said first conduit is a continuous conduit.

### Claim 13 (depends on 1)

A method comprising sampling cells from a bioreactor into a vacuum tube wherein said method comprises:
providing a sampling device as defined in claim 1 wherein said plurality of flow controllers are in a closed position;
aseptically connecting said sampling device to said bioreactor;
creating a closed fluid path from said bioreactor to a sub-port of said sampling device by opening a defined selection of said plurality flow controllers; and,
aseptically connecting said vacuum tube to said sub-port so that said cells to move from the bioreactor into said vacuum tube.

### Claim 14 (depends on 13)

The method as defined in claim 13 wherein each sub-port comprises a needle-provided access device and wherein said fluid path runs through the needle of the access device.

### Claim 15 (depends on 13)

The method as defined in claim 13 wherein said bioreactor is a flexible cell bag.

### Claim 16 (depends on 13)

The method as defined in claim 13 wherein the container is empty.

### Claim 17 (depends on 13)

The method as defined in claim 13 wherein container contains a cell viability stain.

### Claim 18 (depends on 17)

The method as defined in claim 17 wherein the cell viability stain is taken from DRAQS, Hoechst, or propidium iodide.

### Claim 19 (depends on 17)

The method as defined in claim 17 wherein the cells are instantly mixed with the viability stain; removing said container from said bioreactor, and analyzing for viable cell number.

### Claim 20 (depends on 13)

The method as defined in claim 13 wherein container (9) contains single antibodies.

### Claim 21 (depends on 13)

The method as defined in claim 13 wherein container contains multiple antibodies.

### Claim 22 (depends on 20)

The method as defined in claim 20 wherein container contains anti-CD3, anti-CD4 or anti-CD8.

### Claim 23 (depends on 20)

The method as defined in claim 20 comprising cultivating cells in said bioreactor, sampling cells from said bioreactor into said container provided with an antibody wherein the cells are instantly mixed with the antibody; removing said container from said bioreactor, and analyzing for antigen.
